SEC Form 3
FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 07/03/2019 | 3. Issuer Name and Ticker or Trading Symbol BELDEN INC. [ BDC ] | |||||||||||||
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 4,325 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Appreciation Rights | (1) | 03/04/2024 | Common Stock | 537 | 72.57 | D | |
Stock Appreciation Rights | (2) | 02/25/2025 | Common Stock | 1,103 | 89.23 | D | |
Stock Appreciation Rights | (3) | 02/24/2026 | Common Stock | 738 | 52.89 | D | |
Stock Appreciation Rights | (4) | 02/22/2027 | Common Stock | 1,477 | 74.91 | D | |
Stock Appreciation Rights | (5) | 02/28/2028 | Common Stock | 2,312 | 72.73 | D | |
Stock Appreciation Rights | (6) | 02/28/2029 | Common Stock | 9,580 | 61.79 | D |
Explanation of Responses: |
1. 179 SARs became exercisable on March 4, 2015, 179 SARs became exercisable on March 4, 2016 and 179 SARs became exercisable on March 4, 2017. |
2. 368 SARs became exercisable on February 25, 2016, 368 SARs became exercisable on February 25, 2017 and 367 SARs became exercisable on February 25, 2018. |
3. 369 SARs became exercisable on February 24, 2018 and 369 SARs became exercisable on February 24, 2019. |
4. 493 SARs became exercisable on February 22, 2018 and 492 SARs became exercisable on February 22, 2019. The remaining 492 SARs are scheduled to become exercisable on February 22, 2020. |
5. 771 SARs became exercisable on February 28, 2019. 771 SARs will become exercisable on February 28, 2020 and 770 SARs will become exercisable on February 28, 2021. |
6. 3,194 SARs will become exercisable on February 28, 2020, 3,193 SARs will become exercisable on February 28, 2021 and 3,193 will become exercisable on February 28, 2022. |
Remarks: |
/s/ Brian E. Anderson, attorney-in-fact for Ashish Chand | 07/08/2019 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |